Small Caps
31 Jan
dl fusion antibodies plc aim health care healthcare health care providers health care services logo 20230306
Fusion Antibodies validation project with US NIC progresses

Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was progressing as planned.

31 Jan
dl metals one plc met1 basic materials basic resources industrial metals and mining general mining aim logo 20240212 1220
Metals One completes PEA for Finland Black Schist project

Metals One announced on Friday that it has completed a preliminary economic assessment (PEA) for its Finland Black Schist Ni-Cu-Co-Zn Project, identifying the Rautavaara (R1) deposit as the key economic driver.

31 Jan
dl celadon pharmaceuticals plc aim health care healthcare pharmaceuticals and biotechnology cannabis producers logo 20221222
Celadon still seeking finance as it draws down most of facility

Celadon Pharmaceuticals reported on Friday that it has received £0. 897m of a £1m drawdown request from its committed credit facility, with the remaining £0. 1m now expected in February.

31 Jan
dl prospex energy plc aim energy oil gas and coal oil crude producers logo 20230214
Prospex reports rise in production from Selva Malvezzi

Prospex Energy reported a significant increase in production and revenue from the Selva Malvezzi production concession in Italy on Friday, with gross revenue for the fourth quarter reaching €3. 38m, a 91% rise compared to the final three months of 2023.

31 Jan
dl cohort plc aim independent technology group company investor tech digital logo
Cohort completes acquisition of Aussie firm EM Solutions

Cohort announced the completed acquisition of EM Solutions on Friday, following earlier announcements in November and January.

31 Jan
dl faron pharma aim pharmaceuticals drugs medicine medical research and development logo
Faron identifies final patient in BEXMAB phase two study

Faron Pharmaceuticals announced on Friday that it has identified the final patient for its BEXMAB phase two dose optimisation study in refractory or relapsed myelodysplastic syndrome (r/r MDS) and its phase one and two study in frontline high-risk (HR) MDS.

31 Jan
dl reabold resources plc rbd energy energy oil gas and coal oil crude producers aim logo 20230912 1226
Reabold ups stake in West Newton gas development field

Reabold Resources announced on Friday that it has completed the acquisition of additional shares in Rathlin Energy UK from Connaught Oil & Gas for £0. 7m, increasing its equity interest in Rathlin to about 79. 8%.

31 Jan
dl gemfields group aim diamond gemstones mining production investments faberge logo
Gemfields reports progress in disrupted fourth quarter

Gemfields reported total auction revenue of $196m for 2024 on Friday, as it continued to invest in the expansion of its Montepuez Ruby Mine (MRM) in Mozambique.

31 Jan
dl focusrite aim audio music recording podcast hardware technology equipment logo
Focusrite trading as expected amid stocking headwinds

Focusrite said in an update on Friday that trading for the first half of its financial year was expected to align with the board’s expectations, with performance anticipated to be weighted towards the second half as channel destocking in the US eased.

31 Jan
dl alliance pharma plc aim health care healthcare pharmaceuticals and biotechnology pharmaceuticals logo 20230112
Alliance Pharma FY profits seen in line with expectations

International healthcare firm Alliance Pharma said on Friday that FY24 group profits would be in line with expectations despite a modest downturn in revenues.

31 Jan
dl avon protection rubber products armour armor manufacturer producer logo
Avon Technologies trades in line during Q1

Defence products manufacturer Avon Technologies said on Friday that Q1 trading was in line with expectations and that its outlook for the FY remained consistent with previous guidance.